NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
5.78
+0.03 (0.52%)
Sep 15, 2026, 3:34 PM EDT - Market open
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $72.58 million as of September 15, 2026. Its market cap has increased by 203.80% in one year.
Market Cap
72.58M
Enterprise Value
64.54M
1-Year Change
203.80%
Ranking
Category
Stock Price
$5.78
ChartMarket Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $72.58M, an increase of 295.08%. That is a compound annual growth rate of 55.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 72.58M | 50.08% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 77.17M |
| RenovoRx | 76.27M |
| Gain Therapeutics | 75.94M |
| Cingulate | 75.18M |
| BioStem Technologies | 75.15M |
| OKYO Pharma | 73.47M |
| Pliant Therapeutics | 71.21M |
| Alterity Therapeutics | 70.85M |